How lifelong environmental exposures change brain immune cells in Parkinson's disease

Deciphering innate immune signaling mechanisms in glial cells linking lifetime environmental exposures to neuroinflammation, protein aggregation and neurodegeneration in Parkinsons disease

NIH-funded research Colorado State University · NIH-11307127

Researchers are looking at whether lifelong contact with things like pesticides, heavy metals, or infections makes brain support cells turn harmful and lead to Parkinson's disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColorado State University NIH-funded
Lab location1 site (Fort Collins, United States)
Project IDNIH-11307127 on NIH RePORTER

What this research studies

This project uses advanced genetic animal models and molecular lab techniques to study how exposures over a lifetime affect glial cells, the brain's immune-support cells. Scientists will simulate contacts with agents such as pesticides, heavy metals, and infectious microbes and follow how those exposures trigger inflammation, protein clumping, and nerve-cell damage. The team will map the molecular signals that convert glia to a neurotoxic state and trace how those changes contribute to the shift from early symptoms to full neurodegeneration. Results are intended to point to molecular targets for future prevention strategies or treatments for Parkinson's disease.

Who could benefit from this research

Good fit: People with Parkinson's disease or those at higher risk because of long-term exposure to pesticides, heavy metals, or infections are the most relevant group, although the grant primarily supports lab-based research rather than enrolling patients now.

Not a fit: People seeking immediate new treatments or those whose Parkinsonism is purely genetic with no apparent environmental links are unlikely to receive direct benefits from this lab-focused work right away.

Why it matters

Potential benefit: If successful, this work could reveal early molecular signals and targets that help prevent or slow Parkinson's disease.

How similar studies have performed: Previous studies have linked glial inflammation and protein aggregation to Parkinson's, but directly tying lifetime environmental exposures to specific innate immune signaling pathways is a newer and less-tested approach.

Where this research is happening

Fort Collins, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.